Doctor profile · Federal record
Dr. Sara Lohser, MD
Dermatology Physician (CMS: Dermatology) · Mayfield Hts, OH
- NPI 1942468582
- Accepts Medicare
- 18 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5800 Landerbrook Dr Ste 250
Mayfield Hts, OH 44124
(440) 646-1600
fax (440) 646-1505 - Mailing address
-
5800 Landerbrook Dr Ste 200
Mayfield Hts, OH 441244083
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- August 29, 2018
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #35098255
- Medicaid
- OH #0105523
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942468582. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,254
Distinct HCPCS
10
Medicare allowed
$38,148
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 588 | 106 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 205 | 171 | $65 | |
17000 |
Destruction of precancer skin growth, 1 growth | 163 | 128 | $45 | |
11102 |
Biopsy of related skin growth, first growth | 87 | 77 | $26 | |
17110 |
Destruction of skin growth, 1-14 growths | 67 | 61 | $64 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 41 | 36 | $35 | |
11103 |
Biopsy of related skin growth, each additional growth | 36 | 24 | $21 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 30 | 30 | $81 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 24 | 22 | $96 | |
96573 |
Application of light by qualified health care professional to destroy precancer skin growth | 13 | 12 | $220 |
In context: peer comparison
Among 2 peers in Mayfield Hts Dermatology Physician, average services per provider: 186. This provider delivers 6.7× the peer median.Open Payments
Industry payments received
All-time total
$612
Transactions
26
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 6 | $141.16 | |
| Regeneron Healthcare Solutions, INC. | 2 | $61.54 | |
| Smith+Nephew, INC. | 1 | $59.82 | |
| Sun Pharmaceutical Industries INC. | 2 | $52.99 | |
| Amgen INC. | 2 | $48.21 | |
| Janssen Biotech, INC. | 2 | $45.80 | |
| Lilly USA, LLC | 2 | $34.86 | |
| Novartis Pharmaceuticals Corporation | 2 | $34.83 | |
| Biofrontera INC. | 2 | $33.30 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $32.28 | |
| Ucb, INC. | 1 | $23.76 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.23 | |
| Kyowa Kirin, INC. | 1 | $21.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
510
Patients
261
Total drug cost
$75,449
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 84 | 44 | $1,764 |
| Clobetasol Propionate | Generic | 72 | 36 | $5,817 |
| Triamcinolone Acetonide | Generic | 67 | 51 | $658 |
| Fluorouracil | Generic | 58 | 47 | $6,954 |
| Clindamycin Phosphate | Generic | 46 | 22 | $2,811 |
| Nystatin | Generic | 42 | 19 | $558 |
| Mupirocin | Generic | 41 | 18 | $271 |
| Doxycycline Hyclate | Generic | 29 | 11 | $598 |
| Hydrocortisone | Generic | 22 | 13 | $162 |
| Dupixent Pen (Dupilumab) | Brand | 14 | 0 | $53,659 |
Frequently asked questions
What is Dr. Sara Lohser's medical specialty?
Dr. Sara Lohser practices Dermatology Physician in Mayfield Hts, OH.
Where does Dr. Sara Lohser practice?
Dr. Sara Lohser practices at 5800 Landerbrook Dr Ste 250, Mayfield Hts, OH 44124. Office phone: 4406461600.
What is Dr. Sara Lohser's NPI?
Dr. Sara Lohser's National Provider Identifier (NPI) is 1942468582, issued by NPPES.
Does Dr. Sara Lohser accept Medicare assignment?
Yes. Dr. Sara Lohser accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sara Lohser commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.